Article Details
Retrieved on: 2024-07-26 16:13:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The FDA has approved Leqselvi (deuruxolitinib), an oral JAK) inhibitor, for severe alopecia areata.
Article found on: www.empr.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here